News Release Details
Entegris’ Strong Fourth-Quarter Caps Record Year
- Fourth-quarter revenue of
$401.6 million grew 15 percent from prior year - Fourth-quarter GAAP diluted EPS of
$0.57 ; Non-GAAP diluted EPS$0.47 increased 12% from a year ago - Fiscal 2018 revenue of
$1.6 billion increased 15 percent - Fiscal 2018 GAAP diluted EPS of
$1.69 ; Non-GAAP diluted EPS of$1.89 increased 31% from a year ago
The Company reported sales of
Fourth-quarter sales were
Mr. Loy added: “We continue to see tremendous value in our ability to help our customers achieve higher yields, along with new levels of device reliability and performance.
Quarterly Financial Results Summary
(in thousands, except per share data)
GAAP Results |
Q4-2018 |
Q4-2017 |
Q3-2018 |
|||||||||
Net sales | $401,642 | $350,562 | $398,597 | |||||||||
Operating income | $71,308 | $71,152 | $67,975 | |||||||||
Operating margin | 17.8 | % | 20.3 | % | 17.1 | % | ||||||
Net income (loss) | $80,784 | $(28,341) | $48,060 | |||||||||
Diluted earnings (loss) per share (EPS) | $0.57 | $(0.20) | $0.34 | |||||||||
Non-GAAP Results | ||||||||||||
Non-GAAP adjusted operating income | $93,485 | $82,172 | $93,893 | |||||||||
Adjusted operating margin | 23.3 | % | 23.4 | % | 23.6 | % | ||||||
Non-GAAP net income | $66,300 | $59,694 | $65,621 | |||||||||
Non-GAAP EPS | $0.47 | $0.42 | $0.46 | |||||||||
First-Quarter Outlook
For the first quarter ending
Segment Results
The Company reports its results in the following segments:
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, as well as safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
Fourth-Quarter Results Conference Call Details
Management’s slide presentation concerning the results for the fourth quarter and fiscal year, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Tuesday morning.
ABOUT
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to future period guidance; future sales, net income, net income per diluted share, non-GAAP EPS, non-GAAP net income, expenses and other financial metrics; our performance relative to our markets; market and technology trends; the development of new products and the success of their introductions; Company’s capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the effect of the Tax Cuts and Jobs Act on our capital allocation strategy; the impact of the acquisitions we have made and commercial partnerships we have established; our ability to execute on our strategies; the amount and timing of synergies from the proposed transaction with
Additional Information about the Merger and Where to Find It
This communication does not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval. This communication relates to a proposed business combination between
Participants in the Solicitation
Entegris, Inc. and Subsidiaries | ||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||
(In thousands, except per share data) | ||||||||||||||
(Unaudited) | ||||||||||||||
Three months ended | ||||||||||||||
December 31, 2018 | December 31, 2017 | September 29, 2018 | ||||||||||||
Net sales | $ | 401,642 | $ | 350,562 | $ | 398,597 | ||||||||
Cost of sales | 221,902 | 186,883 | 216,881 | |||||||||||
Gross profit | 179,740 | 163,679 | 181,716 | |||||||||||
Selling, general and administrative expenses | 60,707 | 55,018 | 62,358 | |||||||||||
Engineering, research and development expenses | 30,675 | 26,489 | 29,964 | |||||||||||
Amortization of intangible assets | 17,050 | 11,020 | 21,419 | |||||||||||
Operating income | 71,308 | 71,152 | 67,975 | |||||||||||
Interest expense, net | 8,426 | 7,533 | 7,678 | |||||||||||
Other expense, net | 3,176 | 21,696 | 810 | |||||||||||
Income before income tax expense | 59,706 | 41,923 | 59,487 | |||||||||||
Income tax (benefit) expense | (21,078 | ) | 70,264 | 11,427 | ||||||||||
Net income (loss) | $ | 80,784 | $ | (28,341 | ) | $ | 48,060 | |||||||
Basic net income (loss) per common share: | $ | 0.58 | $ | (0.20 | ) | $ | 0.34 | |||||||
Diluted net income (loss) per common share: | $ | 0.57 | $ | (0.20 | ) | $ | 0.34 | |||||||
Weighted average shares outstanding: | ||||||||||||||
Basic | 139,268 | 141,329 | 141,556 | |||||||||||
Diluted | 140,515 | 141,329 | 143,033 | |||||||||||
Entegris, Inc. and Subsidiaries | |||||||||
Condensed Consolidated Statements of Operations | |||||||||
(In thousands, except per share data) | |||||||||
(Unaudited) | |||||||||
|
Twelve months ended | ||||||||
December 31, 2018 | December 31, 2017 | ||||||||
Net sales | $ | 1,550,497 | $ | 1,342,532 | |||||
Cost of sales | 830,666 | 733,547 | |||||||
Gross profit | 719,831 | 608,985 | |||||||
Selling, general and administrative expenses | 246,534 | 216,194 | |||||||
Engineering, research and development expenses | 118,456 | 106,951 | |||||||
Amortization of intangible assets | 62,152 | 44,023 | |||||||
Operating income | 292,689 | 241,817 | |||||||
Interest expense, net | 30,255 | 31,628 | |||||||
Other expense, net | 8,002 | 25,458 | |||||||
Income before income tax expense | 254,432 | 184,731 | |||||||
Income tax expense | 13,677 | 99,665 | |||||||
Net income | $ | 240,755 | $ | 85,066 | |||||
Basic net income per common share: | $ | 1.71 | $ | 0.60 | |||||
Diluted net income per common share: | $ | 1.69 | $ | 0.59 | |||||
Weighted average shares outstanding: | |||||||||
Basic | 141,026 | 141,553 | |||||||
Diluted | 142,610 | 143,518 | |||||||
Entegris, Inc. and Subsidiaries | |||||||||
Condensed Consolidated Balance Sheets | |||||||||
(In thousands) | |||||||||
(Unaudited) | |||||||||
December 31, 2018 | December 31, 2017 | ||||||||
ASSETS | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | 482,062 | $ | 625,408 | ||||||
Trade accounts and notes receivable, net | 222,055 | 183,434 | |||||||
Inventories, net | 268,140 | 198,089 | |||||||
Deferred tax charges and refundable income taxes | 17,393 | 18,012 | |||||||
Other current assets | 39,688 | 32,665 | |||||||
Total current assets | 1,029,338 | 1,057,608 | |||||||
Property, plant and equipment, net | 419,529 | 359,523 | |||||||
Other assets: | |||||||||
Goodwill | 550,202 | 359,688 | |||||||
Intangible assets, net | 295,687 | 182,430 | |||||||
Deferred tax assets and other noncurrent tax assets | 10,162 | 9,103 | |||||||
Other | 12,723 | 7,820 | |||||||
Total assets | $ | 2,317,641 | $ | 1,976,172 | |||||
LIABILITIES AND EQUITY | |||||||||
Current liabilities | |||||||||
Long-term debt, current maturities | 4,000 | 100,000 | |||||||
Accounts payable | 93,055 | 68,762 | |||||||
Accrued liabilities | 141,020 | 99,374 | |||||||
Income tax payable | 31,593 | 22,835 | |||||||
Total current liabilities | 269,668 | 290,971 | |||||||
Long-term debt, excluding current maturities | 934,863 | 574,380 | |||||||
Other liabilities | 101,085 | 117,803 | |||||||
Shareholders’ equity | 1,012,025 | 993,018 | |||||||
Total liabilities and equity | $ | 2,317,641 | $ | 1,976,172 | |||||
Entegris, Inc. and Subsidiaries | ||||||||||||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||||||
December 31, |
December 31, |
December 31, |
December 31, |
|||||||||||||||||
Operating activities: | ||||||||||||||||||||
Net income (loss) | $ | 80,784 | $ | (28,341 | ) | $ | 240,755 | $ | 85,066 | |||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||||||||
Depreciation | 16,880 | 15,035 | 65,116 | 58,208 | ||||||||||||||||
Amortization | 17,050 | 11,020 | 62,152 | 44,023 | ||||||||||||||||
Stock-based compensation expense | 4,385 | 3,849 | 17,112 | 15,306 | ||||||||||||||||
Provision for deferred income taxes | (10,810 | ) | 1,374 | (11,876 | ) | 1,628 | ||||||||||||||
Loss on extinguishment of debt | 2,319 | 20,687 | 2,429 | 20,687 | ||||||||||||||||
Other | 5,804 | 4,267 | 16,278 | 28,295 | ||||||||||||||||
Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||||||||||||||||
Trade accounts and notes receivable | (8,760 | ) | (56 | ) | (17,473 | ) | (15,401 | ) | ||||||||||||
Inventories | (9,312 | ) | (5,330 | ) | (38,100 | ) | (20,214 | ) | ||||||||||||
Accounts payable and accrued liabilities | 29,390 | 8,377 | 19,950 | 15,975 | ||||||||||||||||
Income taxes payable, refundable income taxes and noncurrent taxes payable | (21,188 | ) | 62,852 | (30,381 | ) | 64,516 | ||||||||||||||
Other | (15,215 | ) | (7,993 | ) | (13,386 | ) | (4,716 | ) | ||||||||||||
Net cash provided by operating activities | 91,327 | 85,741 | 312,576 | 293,373 | ||||||||||||||||
Investing activities: | ||||||||||||||||||||
Acquisition of property and equipment | (34,816 | ) | (25,658 | ) | (110,153 | ) | (93,597 | ) | ||||||||||||
Acquisition of business, net of cash | (426 | ) | — | (380,694 | ) | (20,000 | ) | |||||||||||||
Other | (111 | ) | 68 | 4,903 | 1,142 | |||||||||||||||
Net cash used in investing activities | (35,353 | ) | (25,590 | ) | (485,944 | ) | (112,455 | ) | ||||||||||||
Financing activities: | ||||||||||||||||||||
Proceeds from long-term borrowings | 400,000 | 550,000 | 402,000 | 550,000 | ||||||||||||||||
Payments on long-term debt | (108,850 | ) | (385,000 | ) | (135,850 | ) | (460,000 | ) | ||||||||||||
Dividend payments | (9,890 | ) | (9,896 | ) | (39,591 | ) | (9,896 | ) | ||||||||||||
Payments for debt extinguishment costs | — | (16,200 | ) | — | (16,200 | ) | ||||||||||||||
Issuance of common stock | 2,548 | 1,984 | 5,577 | 5,566 | ||||||||||||||||
Taxes paid related to net share settlement of equity awards | (134 | ) | (480 | ) | (14,686 | ) | (5,887 | ) | ||||||||||||
Repurchase and retirement of common stock | (143,781 | ) | (10,000 | ) | (173,781 | ) | (28,000 | ) | ||||||||||||
Other | (8,512 | ) | (7,062 | ) | (9,258 | ) | (8,332 | ) | ||||||||||||
Net cash provided by financing activities | 131,381 | 123,346 | 34,411 | 27,251 | ||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | (186 | ) | 6,714 | (4,389 | ) | 10,850 | ||||||||||||||
Increase (decrease) in cash and cash equivalents | 187,169 | 190,211 | (143,346 | ) | 219,019 | |||||||||||||||
Cash and cash equivalents at beginning of period | 294,893 | 435,197 | 625,408 | 406,389 | ||||||||||||||||
Cash and cash equivalents at end of period | $ | 482,062 | $ | 625,408 | $ | 482,062 | $ | 625,408 | ||||||||||||
Entegris, Inc. and Subsidiaries | ||||||||||||||||||||||||
Segment Information | ||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||||||||||
Net sales |
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||
Specialty Chemicals and Engineered Materials | $ | 133,928 | $ | 125,339 | $ | 131,234 | $ | 530,241 | $ | 485,470 | ||||||||||||||
Microcontamination Control | 158,181 | 115,650 | 151,345 | 552,844 | 436,225 | |||||||||||||||||||
Advanced Materials Handling | 109,533 | 109,573 | 116,018 | 467,412 | 420,837 | |||||||||||||||||||
Total net sales | $ | 401,642 | $ | 350,562 | $ | 398,597 | $ | 1,550,497 | $ | 1,342,532 |
Three months ended | Twelve months ended | |||||||||||||||||||||||
Segment profit1 |
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||
Specialty Chemicals and Engineered Materials | $ | 29,016 | $ | 30,075 | $ | 31,860 | $ | 129,754 | $ | 111,802 | ||||||||||||||
Microcontamination Control | 48,389 | 39,328 | 44,530 | 173,964 | 141,413 | |||||||||||||||||||
Advanced Materials Handling | 16,791 | 18,226 | 19,494 | 82,541 | 59,838 | |||||||||||||||||||
Total segment profit | 94,196 | 87,629 | 95,884 | 386,259 | 313,053 | |||||||||||||||||||
Amortization of intangibles | 17,050 | 11,020 | 21,419 | 62,152 | 44,023 | |||||||||||||||||||
Unallocated expenses | 5,838 | 5,457 | 6,490 | 31,418 | 27,213 | |||||||||||||||||||
Total operating income | $ | 71,308 | $ | 71,152 | $ | 67,975 | $ | 292,689 | $ | 241,817 | ||||||||||||||
1 Beginning in the first quarter of 2018, the Company has changed its definition of segment profit to include an allocation of certain general and administrative costs for the Company’s human resources, finance and information technology functions previously unallocated by the Company. Prior quarter information was recast to reflect the change in the Company’s definition of segment profit.
Entegris, Inc. and Subsidiaries | |||||||||||||||||||||||||
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||
Three months ended | Twelve months ended | ||||||||||||||||||||||||
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||||
Net sales | $ | 401,642 | $ | 350,562 | $ | 398,597 | $ | 1,550,497 | $ | 1,342,532 | |||||||||||||||
Gross profit-GAAP | $ | 179,740 | $ | 163,679 | $ | 181,716 | $ | 719,831 | $ | 608,985 | |||||||||||||||
Adjustments to gross profit: | |||||||||||||||||||||||||
Severance related to organizational realignment | 460 | — | — | 460 | 740 | ||||||||||||||||||||
Charge for fair value mark-up of acquired inventory sold | 3,379 | — | 3,281 | 6,868 | — | ||||||||||||||||||||
Impairment of equipment | — | — | — | — | 5,330 | ||||||||||||||||||||
Adjusted gross profit | $183,579 | $163,679 | $184,997 | $727,159 | $615,055 | ||||||||||||||||||||
Gross margin - as a % of net sales | 44.8 | % | 46.7 | % | 45.6 | % | 46.4 | % | 45.4 | % | |||||||||||||||
Adjusted gross margin - as a % of net sales | 45.7 | % | 46.7 | % | 46.4 | % | 46.9 | % | 45.8 | % | |||||||||||||||
Entegris, Inc. and Subsidiaries | ||||||||||||||||||||||||
Reconciliation of GAAP Segment Profit to Adjusted Operating Income | ||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||||||||||
Segment profit-GAAP |
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||
Specialty Chemicals and Engineered Materials | $ | 29,016 | $ | 30,075 | $ | 31,860 | $ | 129,754 | $ | 111,802 | ||||||||||||||
Microcontamination Control | 48,389 | 39,328 | 44,530 | 173,964 | 141,413 | |||||||||||||||||||
Advanced Materials Handling | 16,791 | 18,226 | 19,494 | 82,541 | 59,838 | |||||||||||||||||||
Total segment profit | 94,196 | 87,629 | 95,884 | 386,259 | 313,053 | |||||||||||||||||||
Amortization of intangible assets | 17,050 | 11,020 | 21,419 | 62,152 | 44,023 | |||||||||||||||||||
Unallocated expenses | 5,838 | 5,457 | 6,490 | 31,418 | 27,213 | |||||||||||||||||||
Total operating income | $ | 71,308 | $ | 71,152 | $ | 67,975 | $ | 292,689 | $ | 241,817 | ||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||||||||||
Adjusted segment profit |
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||
Specialty Chemicals and Engineered Materials 1 | $ | 29,016 | $ | 30,075 | $ | 31,860 | $ | 129,754 | $ | 111,816 | ||||||||||||||
Microcontamination Control 2 | 51,768 | 39,328 | 47,811 | 180,832 | 143,052 | |||||||||||||||||||
Advanced Materials Handling 3 | 17,251 | 18,226 | 19,960 | 83,467 | 67,345 | |||||||||||||||||||
Total adjusted segment profit | 98,035 | 87,629 | 99,631 | 394,053 | 322,213 | |||||||||||||||||||
Amortization of intangible assets4 | — | — | — | — | — | |||||||||||||||||||
Unallocated expenses5 | 4,550 | 5,457 | 5,738 | 23,060 | 23,273 | |||||||||||||||||||
Total adjusted operating income | $ | 93,485 | $ | 82,172 | $ | 93,893 | $ | 370,993 | $ | 298,940 | ||||||||||||||
1 Adjusted segment profit for Specialty Chemicals and Engineered Materials for the twelve months ended
2 Adjusted segment profit for Microcontamination Control excludes charges for fair value mark-up of acquired inventory sold of
3 Adjusted segment profit for Advanced Material Handling excludes loss on sale of subsidiary
4 Adjusted amortization of intangible assets excludes amortization expense of
5 Adjusted unallocated expenses excludes integration expenses of
Entegris, Inc. and Subsidiaries | |||||||||||||||||||||||||
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||
Three months ended | Twelve months ended | ||||||||||||||||||||||||
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||||
Net sales | $ | 401,642 | $ | 350,562 | $ | 398,597 | $ | 1,550,497 | $ | 1,342,532 | |||||||||||||||
Net income (loss) | $ | 80,784 | $ | (28,341 | ) | $ | 48,060 | $ | 240,755 | $ | 85,066 | ||||||||||||||
Adjustments to net income (loss): | |||||||||||||||||||||||||
Income tax (benefit) expense | (21,078 | ) | 70,264 | 11,427 | 13,677 | 99,665 | |||||||||||||||||||
Interest expense, net | 8,426 | 7,533 | 7,678 | 30,255 | 31,628 | ||||||||||||||||||||
Other expense, net | 3,176 | 21,696 | 810 | 8,002 | 25,458 | ||||||||||||||||||||
GAAP - Operating income | 71,308 | 71,152 | 67,975 | 292,689 | 241,817 | ||||||||||||||||||||
Charge for fair value write-up of acquired inventory sold | 3,379 | — | 3,281 | 6,868 | — | ||||||||||||||||||||
Deal costs | — | — | — | 5,121 | — | ||||||||||||||||||||
Integration costs | 1,288 | — | 752 | 3,237 | — | ||||||||||||||||||||
Severance related to organizational realignment | 460 | — | — | 460 | 2,700 | ||||||||||||||||||||
Impairment of equipment and intangibles 1 | — | — | — | — | 10,400 | ||||||||||||||||||||
Loss on sale of subsidiary | — | 466 | 466 | — | |||||||||||||||||||||
Amortization of intangible assets | 17,050 | 11,020 | 21,419 | 62,152 | 44,023 | ||||||||||||||||||||
Adjusted operating income | 93,485 | 82,172 | 93,893 | 370,993 | 298,940 | ||||||||||||||||||||
Depreciation | 16,880 | 15,035 | 16,537 | 65,116 | 58,208 | ||||||||||||||||||||
Adjusted EBITDA | $ | 110,365 | $ | 97,207 | $ | 110,430 | $ | 436,109 | $ | 357,148 | |||||||||||||||
Adjusted operating margin | 23.3 | % | 23.4 | % | 23.6 | % | 23.9 | % | 22.3 | % | |||||||||||||||
Adjusted EBITDA - as a % of net sales | 27.5 | % | 27.7 | % | 27.7 | % | 28.1 | % | 26.6 | % | |||||||||||||||
1 Includes product line impairment charges of
Includes intangible impairment charge of
Includes product line impairment charge of
Includes product line impairment charge of
Entegris, Inc. and Subsidiaries | |||||||||||||||||||||||||
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Earnings per Share | |||||||||||||||||||||||||
(In thousands, except per share data) | |||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||
Three months ended | Twelve months ended | ||||||||||||||||||||||||
December 31, |
December 31, |
September 29, |
December 31, |
December 31, |
|||||||||||||||||||||
GAAP net income (loss) | $ | 80,784 | $ | (28,341 | ) | $ | 48,060 | $ | 240,755 | $ | 85,066 | ||||||||||||||
Adjustments to net income (loss): | |||||||||||||||||||||||||
Charge for fair value write-up of inventory acquired | 3,379 | — | 3,281 | 6,868 | — | ||||||||||||||||||||
Deal costs | — | — | — | 5,121 | — | ||||||||||||||||||||
Integration costs | 1,288 | — | 752 | 3,237 | — | ||||||||||||||||||||
Severance related to organizational realignment | 460 | — | — | 460 | 2,700 | ||||||||||||||||||||
Impairment of equipment and intangibles 1 | — | — | — | — | 13,200 | ||||||||||||||||||||
Loss on debt extinguishment | 2,319 | 20,687 | — | 2,319 | 20,687 | ||||||||||||||||||||
Loss on sale of subsidiary | — | — | 466 | 466 | — | ||||||||||||||||||||
Amortization of intangible assets | 17,050 | 11,020 | 21,419 | 62,152 | 44,023 | ||||||||||||||||||||
Tax effect of adjustments to net income and discrete items2 | (5,603 | ) | (10,385 | ) | (5,797 | ) | (17,812 | ) | (26,046 | ) | |||||||||||||||
Tax effect of legal entity restructuring | (34,478 | ) | — | — | (34,478 | ) | — | ||||||||||||||||||
Tax effect of Tax Cuts and Jobs Act | 1,101 | 66,713 | (2,560 | ) | 683 | 66,713 | |||||||||||||||||||
Non-GAAP net income | $ | 66,300 | $ | 59,694 | $ | 65,621 | $ | 269,771 | $ | 206,343 | |||||||||||||||
Diluted earnings (loss) per common share | $ | 0.57 | $ | (0.20 | ) | $ | 0.34 | $ | 1.69 | $ | 0.59 | ||||||||||||||
Effect of adjustments to net income | $ | (0.10 | ) | $ | 0.61 | $ | 0.12 | $ | 0.20 | $ | 0.85 | ||||||||||||||
Diluted non-GAAP earnings per common share | $ | 0.47 | $ | 0.42 | $ | 0.46 | $ | 1.89 | $ | 1.44 | |||||||||||||||
1Includes product line impairment charges of
Includes intangible impairment charge of
Includes product line impairment charge of
Includes product line impairment charge of
Includes product line impairment charge of
2The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005299/en/
Source:
Bill Seymour
VP of Investor Relations
T +1 978 436 6500
irelations@entegris.com